DTR — Diagnostear Technologies Balance Sheet
0.000.00%
Last trade - 00:00- CA$19.40m
- CA$17.91m
Annual balance sheet for Diagnostear Technologies, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | |
| Standards: | — | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final |
| Cash | |||
| Cash and Short Term Investments | — | 0.275 | 2.48 |
| Total Other Current Assets | |||
| Total Current Assets | — | 0.286 | 2.62 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 1.52 | 1.48 |
| Long Term Investments | |||
| Total Assets | — | 1.81 | 4.14 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 0.329 | 0.292 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Minority Interest | |||
| Total Other Liabilities | |||
| Total Liabilities | — | 0.639 | 0.796 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | — | 1.17 | 3.35 |
| Total Liabilities & Shareholders' Equity | — | 1.81 | 4.14 |
| Total Common Shares Outstanding |